Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial? - Kate A. McBride; Mandy L. Ballinger; Timothy E. Schlub; Mary-Anne Young; Martin H. N. Tattersall; Judy Kirk; Ros Eeles; Emma Killick; Leslie G. Walker; Sue Shanley; David M. Thomas; Gillian Mitchell (Familial Cancer, 2017)

Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls - Sibel Saya; Emma Killick; Sarah Thomas; Natalie Taylor; Elizabeth K. Bancroft; Jeanette Rothwell; Sarah Benafif; Alexander Dias; Christos Mikropoulos; Jenny Pope; Anthony Chamberlain; Ranga Gunapala; et al. (Familial Cancer, 2017)